Logo

Agilent

In Brief This Week: DermTech, Cerca Biotech, Colossal Biosciences, Biocept, Abbott, More

News items for the week of Sept. 18, 2023

Agilent, National Cancer Center Singapore to Collaborate on Profiling Cancers Prevalent in Asia

The agreement will aid research into tumor genomes and provide data that can be applied in patient care, clinical trials, and diagnostics development.

With Resolution Bio Acquisition, Exact Sciences Takes Aim at NGS-Based Liquid Biopsy Market
Premium

Industry insiders said Resolution Bio may be a better fit under Exact Sciences and think it could augment Exact's cancer testing portfolio.

Agilent Technologies Selling Resolution Bioscience to Exact Sciences

The firms announced a deal, for an undisclosed sum, about one month after Agilent announced plans to shutter the Resolution Bioscience business.

People in the News at Agilent Technologies, ASHG, Veracyte, Enzo Biochem, Renalytix, More

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Sept. 4, 2023

Aug 21, 2023

Top Five Articles on GenomeWeb Last Week: Agilent, Bruker, Foundation Medicine, More

Aug 15, 2023

Agilent Technologies Shuttering Resolution Bioscience Business
Premium

Aug 11, 2023

In Brief This Week: MiRxes, Oncocyte, OpGen, Biodesix, Element Biosciences, More

Jun 16, 2023

In Brief This Week: Enzo Biochem, Epigenomics, OpGen, Precipio, Agilent Technologies, More

May 23, 2023

Agilent Technologies Fiscal Q2 Revenues Rise 7 Percent as Firm Lowers 2023 Guidance

May 19, 2023

In Brief This Week: Biocept, Agilent Technologies, Cellsway, Omega Genetik, GenScript Biotech, More

May 18, 2023

US Patent Office Invalidates Two Agilent Technologies Patents Covering CRISPR Guide RNAs

May 12, 2023

In Brief This Week: Bruker, Singlera Genomics, Agilent, Ginkgo, Danaher, DiaCarta, DermTech

May 11, 2023

Barclays Initiates Coverage of Agilent

Mar 14, 2023

Sophia Genetics, Agilent Partner on Cancer Analysis Product

Mar 3, 2023

New Products Posted to GenomeWeb: Lybe Scientific, Cardio Diagnostics, Agilent, More

Mar 1, 2023

Agilent Technologies Fiscal Q1 Revenues Rise 5 Percent

Feb 24, 2023

In Brief This Week: Personalis, Biocartis, Opko Health, Berkeley Lights, More

Jan 23, 2023

Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment

Jan 13, 2023

In Brief This Week: MDxHealth, Agilent Technologies, IsoPlexis, IntegraGen, More

Jan 11, 2023

Evolving Akoya Biosciences Touts CDx Partnerships at JP Morgan Conference

Jan 11, 2023

JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Agilent, Roche, Seer, More

Jan 6, 2023

Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis

Jan 4, 2023

Agilent Technologies Acquires NGS Target Enrichment Firm Avida Biomed

Dec 21, 2022

Genomics Firms Tackle Carbon Emissions, Face Obstacles to Net-Zero Goals From Suppliers, Shipping
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.